Be a Smart Investor
Monday, November 6, 2017
Medicines Co., Alnylam Pharma Initiate Phase III Clinical Trial Of Inclisiran
The Medicines Co. (MDCO) and Alnylam Pharmaceuticals, Inc. (ALNY) said they have initiated a Phase III clinical program for inclisiran.
from RTT - Biotech http://ift.tt/2zhYQtf
via
IFTTT
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment